Final SCCS Opinion on CBD

Final SCCS Opinion on CBD

Summary: On 24 April 2026, the SCCS concluded that pure CBD is safe for use in dermal and oral cosmetic products at concentrations up to 0.19%, with THC impurities permitted up to 0.00025%. Products that may result in inhalation exposure were not assessed. On 24 April...
Final SCCS Opinion on CBD

Final SCCS Opinion on BHA

Summary: The SCCS has finalized its safety opinion on butylated hydroxyanisole (BHA), concluding it is safe for use in leave-on and rinse-off cosmetics at concentrations up to 0.07%. This approval applies exclusively to dermal application and specifically excludes...
Final SCCS Opinion on CBD

Draft SCCS Opinion on Heliotropine

Summary: Substance: HeliotropineEffected Products: Fine fragrances for adultsDate of Implementation: TBC On 15 April 2026, the Scientific Committee on Consumer Safety (SCCS) published its draft opinion on the safety of Heliotropine in fine fragrances for...